Search results
William spotted helping out at charity while Charles returns to public duties
The US Sun· 2 days agoPRINCE William is today helping an Earthshot charity - as King Charles returns to public duties for...
Legal & General updates critical illness cover
Life Insurance International via Yahoo Finance· 2 days agoLegal & General has also evolved its policies to better reflect the modern medical landscape when it comes to critical illness cover. Updates include:...
Junshi Biosciences Announces NDA Acceptance in Hong Kong for Toripalimab
Morningstar· 7 days agoShanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization ...
Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting
Char-Koosta News· 7 days agoSAN FRANCISCO and SUZHOU, China, April 24, 2024 /PRNewswire/ -- Innovent Biologics, Inc....
Edison Oncology's Orotecan®: A Brighter Future For The Treatment of Recurrent Pediatric Cancers
International Business Times· 3 days agoDiagnosis of pediatric cancer is one of the worst news a family can receive. Having a young family member with cancer affects the entire family's dynamics and causes significant anxiety and ...
Cedars-Sinai Guerin Children’s Expert Reelected to Leadership Position of Pediatric Oncology...
Newswise· 3 days agoLOS ANGELES (April 29, 2024) -- Cedars-Sinai Guerin Children’s pediatric oncologist Leo Mascarenhas, MD, MS, has been reelected as Children’s Oncology Group (COG) voting body chair for a second ...
Rakovina Therapeutics Inc. Announces 2023 Financial Results and Provides Corporate Update
Digital Journal· 5 days agoOn April 19, 2023, we presented new preclinical in vitro and in vivo data demonstrating the potential of our kt-3000 series against treatment-resistant Ewing sarcoma, a rare ...
Moleculin Announces Formation of Scientific Advisory Board to Support Development of Annamycin
KTLA-TV Los Angeles· 12 hours agoMoleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses ...
MD Anderson and Replay announce FDA clearance of IND application for first-in-class PRAME-targeted...
Newswise· 2 days agoMD Anderson and Replay today announced that the Food & Drug Administration (FDA) has issued a ‘safe to proceed’ for the Investigational New Drug (IND) appli
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 2 days agoReplay and MD Anderson announce FDA clearance of IND application for first-in-class PRAME-targeted T-Cell Receptor Natural Killer (TCR-NK) cell therapy for hematological malignancies Phase 1/2 study in patients with relapsed/refractory AML
